The complete guide to Ozempic (semaglutide) — the original game-changer

Ozempic is the medication that brought GLP-1s into the cultural mainstream. FDA-approved for type 2 diabetes in 2017, it contains semaglutide — the same molecule as Wegovy — but at a lower maximum dose (2.0mg vs 2.4mg). It is frequently prescribed off-label for weight management and remains one of the most widely used GLP-1 medications in the world.

How Ozempic works

Like all semaglutide-based medications, Ozempic activates GLP-1 receptors throughout the body. It improves blood sugar control by stimulating insulin release when glucose is high, reduces appetite through brain-based satiety signaling, and slows gastric emptying to promote fullness. The combined effect produces both glycemic control and significant weight loss.

What the clinical trials show

• •SUSTAIN program: The original diabetes trial program showing superior A1C reduction compared to other diabetes medications.
• •FLOW trial (Nature Medicine 2024, N=3,533): Semaglutide reduced the risk of kidney disease progression, kidney failure, or cardiovascular death by 24% in patients with chronic kidney disease and type 2 diabetes. This led to an FDA approval for CKD risk reduction in January 2025.
• •Weight loss: At 2.0mg, Ozempic produces approximately 10-14% body weight loss. This is slightly less than Wegovy's 2.4mg dose (14.9%) because of the lower maximum dose, but still clinically significant.

Dosing schedule

• •Weeks 1-4: 0.25mg
• •Weeks 5-8: 0.5mg
• •Weeks 9-12: 1.0mg
• •Week 13+: Up to 2.0mg (maximum)

The titration is the same as Wegovy's first three steps, but stops at 2.0mg rather than continuing to 2.4mg.

Side effects

Side effects are consistent with the GLP-1 class:

• •Nausea (~50%): Most intense during titration, usually resolves within 4-6 weeks at each dose level. Standard management: small meals, ginger, cold foods, protein-first eating.
• •Stomach pain (~24%): Often improves after the first few doses at each level.
• •Constipation (~20%): Hydration, fiber, walking after meals.
• •Diarrhea (~26%): Usually transient around dose changes.

Side effects tend to be milder overall than tirzepatide, partly because the maximum dose is lower.

Ozempic vs Wegovy: what's the difference?

Same molecule (semaglutide), different doses and FDA indications. Ozempic is approved for type 2 diabetes and caps at 2.0mg. Wegovy is approved for weight management and goes up to 2.4mg. If your primary goal is weight loss and you can access Wegovy, the additional 0.4mg provides incrementally better results. If you have type 2 diabetes, Ozempic may be covered more readily by insurance.

Many patients start on Ozempic for diabetes and find the weight loss effects significant enough that switching to Wegovy isn't necessary.

The kidney protection story

The FLOW trial was groundbreaking. A 24% reduction in kidney disease progression is clinically meaningful — it means fewer patients progressing to dialysis or kidney failure. If you have diabetes and any stage of chronic kidney disease, this data is particularly relevant to discuss with your provider.

What to expect

• •Month 1-2: Blood sugar improvements often come first. Appetite suppression builds gradually.
• •Month 3-6: Weight loss becomes consistent at the 1.0mg-2.0mg doses. Typically 1-1.5 lbs/week.
• •Month 6-12: Peak weight loss of 10-14% for most patients.
• •Ongoing: Strong A1C control maintained long-term. Kidney protective benefits accumulate over time.

Cost and access

Ozempic's list price is approximately $998/month. Most commercial insurance covers Ozempic for type 2 diabetes patients, making it more accessible than weight-specific GLP-1s. Manufacturer savings cards and GoodRx can further reduce costs.

The bottom line

Ozempic remains an excellent choice, especially for patients with type 2 diabetes. It offers strong glycemic control, meaningful weight loss, cardiovascular benefits (via the SELECT trial data on semaglutide), and newly proven kidney protection. While newer medications may show greater weight loss, Ozempic's broad availability and insurance coverage make it a practical and effective option for millions of patients.